Insuman Rapid Solostar (Insulin Human)

Insuman Rapid Solostar is a rapid‑acting insulin that works within the carbohydrate metabolism pathway to lower blood glucose.

• Type 1 Diabetes: provides prompt reduction of elevated glucose levels after meals.
• Type 2 Diabetes: improves overall glycaemic control when oral agents are insufficient.
• Diabetic Ketoacidosis: supplies rapid insulin to correct hyperglycaemia and suppress ketone production.

• Insulin Human binds to insulin receptors on cell membranes, activating the receptor’s intrinsic tyrosine kinase activity. This triggers intracellular signaling cascades that promote translocation of GLUT‑4 transporters to the cell surface, enhancing glucose uptake in muscle and adipose tissue, while inhibiting hepatic gluconeogenesis and glycogenolysis, thereby lowering circulating glucose.

Insuman Rapid Solostar may cause a range of adverse reactions.

Common Side Effects

• Hypoglycaemia: symptoms of low blood sugar such as sweating, tremor, or confusion.
• Injection‑site reactions: redness, swelling, or itching at the injection site.
• Weight gain: increased caloric storage associated with improved glucose utilisation.
• Lipodystrophy: localized changes in subcutaneous fat with repeated injections.
• Mild allergic response: rash or urticaria.
• Transient nausea: occasional stomach discomfort after injection.

Serious or Rare Side Effects

• Severe hypoglycaemia: seizures, loss of consciousness, or coma.
• Anaphylactic reaction: difficulty breathing, swelling of face or throat.
• Hypokalemia: low potassium levels leading to muscle weakness or arrhythmia.
• Persistent hyperglycaemia: unexpected high blood glucose despite dosing.
• Edema: swelling of extremities due to fluid retention.
• Insulin antibody formation: reduced drug efficacy over time.

When using Insuman Rapid Solostar, consider the following precautions.

• Dose adjustment: titrate dose based on frequent blood glucose monitoring.
• Hypoglycaemia risk: avoid administration if blood glucose is already low.
• Renal or hepatic impairment: monitor closely and adjust dose as needed.
• Pregnancy and lactation: safety not fully established; use only if benefits outweigh risks.
• Driving and operating machinery: be aware of possible hypoglycaemia‑related impairment.
• Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake the vial.

Insuman Rapid Solostar can interact with several other medicines.

Major Interactions (Avoid)

• Sulfonylureas or meglitinides: combined use may cause severe hypoglycaemia.
• Beta‑blockers: may mask hypoglycaemia symptoms, delaying recognition.
• Alcohol: can potentiate insulin’s glucose‑lowering effect, increasing hypoglycaemia risk.

Moderate Interactions (Monitor Closely)

• Thiazolidinediones: additive glucose‑lowering effect, require glucose monitoring.
• ACE inhibitors or ARBs: may enhance insulin sensitivity, modestly lowering glucose.
• Diuretics: can affect electrolyte balance, influencing insulin action.